CDSCO Panel Approves Sun Pharma’s Phase IV Clinical Trial for Dual Release Pantoprazole in Treating Gastroesophageal Reflux Disease (GERD)
Sun Pharma, a leading pharmaceutical company, has announced that its Phase IV study on dual release pantoprazole for the treatment of Gastroesophageal Reflux Disease (GERD) has received acceptance from the Central Drugs Standard Control Organization (CDSCO) panel....
Volini by Sun Pharma Introduces ‘Uparna’, a Groundbreaking Initiative for Devotees Traveling to Pandharpur
Sun Pharmaceutical Industries Limited, India's leading pharmaceutical company, has launched a unique initiative through its pain relief brand, Volini. During the annual Pandharpur Wari pilgrimage in Maharashtra, one of the oldest and most significant spiritual...
Fortis acquires Shrimann hospital in a massive Rs 462 crore deal
Fortis Healthcare has expanded its presence in Punjab by acquiring the 228-bed Shrimann Superspecialty Hospital for a consideration of Rs 462 crore. This marks the fifth hospital of Fortis in Punjab, with existing hospitals in Ludhiana, Mohali, and Amritsar. The...
Biocon Ltd (BOM:532523) Reports Strong Revenue Increase in Q1 2026 Earnings, Despite Margin Pressures, as Noted by GuruFocus on Investing.com Canada.
Biocon Ltd, an Indian biopharmaceutical company, reported its Q1 2026 earnings, showcasing strong revenue growth despite margin pressures. Here are the highlights from the earnings call: Revenue Growth: Biocon Ltd posted a robust revenue growth of 23% year-over-year...
ZDS-Varenicline, a smoking cessation medication developed by Zydus Lifesciences, receives approval from Health Canada, as reported by geneonline.com.
Zydus Lifesciences, a leading pharmaceutical company, has received approval from Health Canada for its smoking cessation drug, ZDS-Varenicline. This approval marks a significant milestone for the company, as it expands its presence in the Canadian market....
Burn Pain Treatment Industry: Research, Therapies, and Key Players Including Johnson & Johnson, Mankind Pharma, Perrigo Company, Pfizer, Smith & Nephew, Sun Pharmaceutical, and Trio Li.
The burn pain market is a growing industry that is expected to expand due to the increasing incidence of burn injuries worldwide. According to DelveInsight, the market is driven by the rising demand for effective pain management therapies for burn patients. Burn pain...
CureVac and GSK have reached an agreement to settle their ongoing patent dispute with Pfizer and BioNTech.
CureVac, a German biotechnology company, and GlaxoSmithKline (GSK) have agreed to resolve a patent dispute litigation with Pfizer and BioNTech related to COVID-19 vaccine technology. The dispute centered on the use of messenger RNA (mRNA) technology, which is a key...
The Steroid Implant Market is Expected to Experience Significant Growth, with Key Players such as Novartis, Allergan, and Pfizer Driving the Trend.
The Global Steroid Implant Market Study, conducted by HTF Market Intelligence, provides a comprehensive analysis of the market from 2025 to 2033. The report spans over 143 pages and covers the product and industry scope, market prognosis, and status. The market is...
CDSCO Panel Approves Sun Pharma’s Phase IV Clinical Trial for Dual Release Pantoprazole in Treating Gastroesophageal Reflux Disease (GERD)
Sun Pharma, a leading pharmaceutical company, has announced that its Phase IV study on dual release pantoprazole for the treatment of Gastroesophageal Reflux Disease (GERD) has received acceptance from the Central Drugs Standard Control Organization (CDSCO) panel....
Volini by Sun Pharma Introduces ‘Uparna’, a Groundbreaking Initiative for Devotees Traveling to Pandharpur
Sun Pharmaceutical Industries Limited, India's leading pharmaceutical company, has launched a unique initiative through its pain relief brand, Volini. During the annual Pandharpur Wari pilgrimage in Maharashtra, one of the oldest and most significant spiritual...
Delhi High Court Grants Sun Pharma Reprieve by Restraining Use of BERIVITAL, BEZOLIC, and DOZE-30 Due to Trademark Infringement
The Delhi High Court has granted relief to Sun Pharma, a prominent pharmaceutical company, by barring the use of three trademarks - BERIVITAL, BEZOLIC, and DOZE-30 - due to trademark infringement. This decision is a significant victory for Sun Pharma, as it protects...
Sun Pharma Reports Favorable Phase 3 Trial Outcomes for Tildrakizumab in Treating Psoriatic Arthritis
Sun Pharma has announced positive top-line results from two phase 3 clinical trials, INSPIRE-1 and INSPIRE-2, evaluating the efficacy and safety of tildrakizumab 100 mg (Ilumya) in patients with active psoriatic arthritis. The studies, which enrolled over 800...
Authorities with the DCA have seized counterfeit Levipil 500 tablets.
The Telangana State Drugs Control Administration (DCA) has cracked down on counterfeit medication in the region, seizing fake Levipil 500 tablets, which are used to treat epilepsy. The tablets were falsely labeled as products of Sun Pharma Laboratories Ltd, a...
Fake versions of Sun Pharma’s cholesterol-lowering medications confiscated in Hyderabad
In a significant crackdown on counterfeit pharmaceuticals, the Telangana Drugs Control Administration (DCA) has seized fake versions of heart medications Rosuvas F 20 and Rosuvas F 10 in Hyderabad's Koti area. The counterfeit cholesterol-lowering drugs, labeled under...
Authorities in Hyderabad confiscate fake Sun Pharma cholesterol medication valued at Rs 3 lakhs
In a significant crackdown on counterfeit medicines, a large consignment of fake Sun Pharma cholesterol-lowering drugs worth approximately Rs 3 lakhs was seized in Hyderabad. The seizure is a result of a coordinated effort between law enforcement agencies and...
Sun Pharmaceutical Industries Appoints Kirti Ganorkar as MD Amidst Top-Level Restructuring – MSN
Sun Pharmaceutical Industries, one of India's largest pharmaceutical companies, has announced a significant leadership overhaul with the appointment of Kirti Ganorkar as its new Managing Director. This move is part of a broader effort to revamp the company's...
Natco Pharma names TC Mallikarjun as its new Vice President.
Natco Pharma, a leading pharmaceutical company, has announced the appointment of TC Mallikarjun as Vice President - Quality Control (QC) at its Kothur Pharma Division. This appointment is a significant development for the company, as it continues to strengthen its...
Access to the Request Has Been Denied
It appears that you have encountered an error while trying to access the website www.tipranks.com. The error message indicates that your request was blocked by Link11 Web Application Security, which is a security system designed to protect websites from malicious...
US FDA issues single Form 483 observation to NATCO Pharma’s Hyderabad plant following audit.
NATCO Pharma, a leading pharmaceutical company based in Hyderabad, India, has received a positive outcome from a recent US Food and Drug Administration (US FDA) audit. The company's plant, located in Hyderabad, was inspected by the US FDA, and the audit resulted in...
Natco Pharma’s Q4 net profit sees 5% year-over-year increase, reaching ₹406 crore.
Natco Pharma Ltd, an Indian multinational pharmaceutical company, reported a 5% increase in consolidated net profit for the quarter ended March 31, 2025, with a net profit of ₹406 crore compared to ₹386.3 crore in the same period last year. The company's quarterly...
Divis Laboratories signs long-term manufacturing and supply pact with international pharmaceutical company.
Divis Laboratories has secured a long-term manufacturing and supply agreement with a global pharmaceutical company. Under the terms of the agreement, Divis will manufacture and supply advanced intermediates to the pharma company, with the details of the commercial...
Unlocking the Emerging Opportunities in India’s Pharmaceutical Industry
The Indian pharmaceutical sector has demonstrated robust growth over the past year, driven by a new trade agreement with the European Union that reduces tariffs on key drug exports. This agreement is expected to enhance India's position as a global supplier of generic...
SMA patients welcome Natco’s development of a generic drug, calling on the government to ensure timely access to it.
The article reports on the recent development of a generic drug by Natco Pharmaceuticals, a leading Indian pharmaceutical company, which is expected to benefit patients suffering from Spinal Muscular Atrophy (SMA). SMA is a genetic disorder that affects the muscles,...
Patents for Pharmaceuticals: Balancing Exclusive Rights with Public Welfare
The Indian court, Justice Mini Pushkarna, recently ruled against granting an injunction in favor of Roche, a pharmaceutical company, in a landmark case involving the patent dispute over the drug Risdiplam, used to treat Spinal Muscular Atrophy (SMA). The court's...
CDSCO Panel Approves Sun Pharma’s Phase IV Clinical Trial for Dual Release Pantoprazole in Treating Gastroesophageal Reflux Disease (GERD)
Sun Pharma, a leading pharmaceutical company, has announced that its Phase IV study on dual release pantoprazole for the treatment of Gastroesophageal Reflux Disease (GERD) has received acceptance from the Central Drugs Standard Control Organization (CDSCO) panel....
Volini by Sun Pharma Introduces ‘Uparna’, a Groundbreaking Initiative for Devotees Traveling to Pandharpur
Sun Pharmaceutical Industries Limited, India's leading pharmaceutical company, has launched a unique initiative through its pain relief brand, Volini. During the annual Pandharpur Wari pilgrimage in Maharashtra, one of the oldest and most significant spiritual...
Fortis acquires Shrimann hospital in a massive Rs 462 crore deal
Fortis Healthcare has expanded its presence in Punjab by acquiring the 228-bed Shrimann Superspecialty Hospital for a consideration of Rs 462 crore. This marks the fifth hospital of Fortis in Punjab, with existing hospitals in Ludhiana, Mohali, and Amritsar. The...
Biocon Ltd (BOM:532523) Reports Strong Revenue Increase in Q1 2026 Earnings, Despite Margin Pressures, as Noted by GuruFocus on Investing.com Canada.
Biocon Ltd, an Indian biopharmaceutical company, reported its Q1 2026 earnings, showcasing strong revenue growth despite margin pressures. Here are the highlights from the earnings call: Revenue Growth: Biocon Ltd posted a robust revenue growth of 23% year-over-year...
ZDS-Varenicline, a smoking cessation medication developed by Zydus Lifesciences, receives approval from Health Canada, as reported by geneonline.com.
Zydus Lifesciences, a leading pharmaceutical company, has received approval from Health Canada for its smoking cessation drug, ZDS-Varenicline. This approval marks a significant milestone for the company, as it expands its presence in the Canadian market....
Burn Pain Treatment Industry: Research, Therapies, and Key Players Including Johnson & Johnson, Mankind Pharma, Perrigo Company, Pfizer, Smith & Nephew, Sun Pharmaceutical, and Trio Li.
The burn pain market is a growing industry that is expected to expand due to the increasing incidence of burn injuries worldwide. According to DelveInsight, the market is driven by the rising demand for effective pain management therapies for burn patients. Burn pain...
CureVac and GSK have reached an agreement to settle their ongoing patent dispute with Pfizer and BioNTech.
CureVac, a German biotechnology company, and GlaxoSmithKline (GSK) have agreed to resolve a patent dispute litigation with Pfizer and BioNTech related to COVID-19 vaccine technology. The dispute centered on the use of messenger RNA (mRNA) technology, which is a key...
The Steroid Implant Market is Expected to Experience Significant Growth, with Key Players such as Novartis, Allergan, and Pfizer Driving the Trend.
The Global Steroid Implant Market Study, conducted by HTF Market Intelligence, provides a comprehensive analysis of the market from 2025 to 2033. The report spans over 143 pages and covers the product and industry scope, market prognosis, and status. The market is...
Cipla’s CEO responds to tariff threats, highlighting the company’s diversified business model as a key strength.
Cipla, a leading pharmaceutical company, is confident in its ability to withstand the potential impact of tariff threats on its business. In a recent interview, Cipla's CEO, Umang Vohra, emphasized that the company has "one of the most well-diversified models" in the...
Global Digoxin Industry Analysis: An In-Depth Report Featuring Key Players Such as Pfizer, Novartis, and Mylan
The Global Digoxin Market study, recently introduced by HTF MI, provides a comprehensive overview of the product and industry scope, as well as an in-depth analysis of the market outlook and status from 2025 to 2031. The market is segmented by key regions, including...
Lupin Splits Off Its Consumer Healthcare Business to Form Independent Company
Lupin, a leading pharmaceutical company, has created a new subsidiary called LupinLife Consumer Healthcare Ltd to house its consumer healthcare business. This move is in line with a growing trend among pharmaceutical companies, both in India and globally, to separate...
The US Food and Drug Administration has issued a single observation for Cipla’s Bommasandra manufacturing facility.
The US Food and Drug Administration (USFDA) has issued a single observation for Cipla's Bommasandra facility, which is a pharmaceutical manufacturing plant located in Karnataka, India. The observation was made after the USFDA conducted an inspection of the facility...
Amit Patel has been promoted to lead Consumer Marketing Excellence as its new Head.
Amit Patel has been promoted to Head of Consumer Marketing Excellence at Cipla India, a leading pharmaceutical company. In his new role, Patel will be responsible for driving consumer marketing across various therapeutic areas, with a focus on building patient-centric...
The Indian market for active pharmaceutical ingredients has experienced significant revenue generation.
The India Active Pharmaceutical Ingredients (API) market is expected to experience significant growth, with an estimated value of USD 14.81 billion in 2025 and a projected value of USD 25.23 billion by 2032, at a compound annual growth rate (CAGR) of 7.9%. This growth...
Cipla Limited and its division EMEU, have been honoured at the prestigious Healthcare Asia Pharma Awards 2025.
Cipla EMEU and Cipla Limited have been recognized at the Healthcare Asia Pharma Awards 2025 for their innovative initiatives. Cipla EMEU received the ESG Program of the Year - India award for its Ahead & Apart campaign, which promotes sustainable practices in the...
Cipla to Report Q4 FY 2025 Earnings on May 13, Dividend Payment Possible
Pharmaceutical company Cipla has announced the date for its earnings release for the fourth quarter and full year ended March 31, 2025. The company's Board of Directors is scheduled to meet on Tuesday, May 13, 2025, to consider and approve the standalone and...
Future Female Forward | Apollo HealthCo’s Shobana Kamineni: ‘We’re aiming for a phenomenal, blockbuster demerger’
Shobana Kamineni, Executive Chairperson of Apollo HealthCo, has made a bold prediction that the company's turnover will soon surpass that of Apollo Hospitals. This statement was made at the CNBC-TV18's Future Female Forward event in Bengaluru, where Kamineni...
Nourishment comes first for optimal well-being
The importance of food in maintaining overall health and wellbeing has been emphasized for centuries. As stated in the ancient Sanskrit text, Charaka Samhita, "Annam hi jeevanam" or "food is life itself". This phrase was recently quoted by Dr. Anupam Sibal, Group...
Apollo Hospitals introduces a comprehensive nutrition guide to encourage proactive wellness.
Apollo Hospitals has launched a new book titled "My Food, My Health", a comprehensive guide to combating lifestyle diseases through evidence-based nutrition. The book was released in Chennai and is designed to support preventive healthcare through nutrition therapy....
AI has the potential to revolutionize India’s healthcare industry, according to Apollo’s Shobhana Kamineni.
Shobhana Kamineni, the executive chairperson of Apollo Hospitals, believes that artificial intelligence (AI) has the potential to transform India's healthcare sector more deeply than other industries. According to Kamineni, India faces significant challenges in terms...
At 92, a resilient entrepreneur still commutes to the office every day, spearheading India’s largest healthcare network as the founder of [company name], a feat achieved by the indefatigable [his name].
Dr. Prathap C. Reddy is a 92-year-old man who still goes to office every day, six days a week, and is the guiding force behind Apollo Hospitals, India's largest healthcare network. He founded Apollo Hospitals in 1983, which was India's first corporate hospital,...
Larsen & Toubro to construct hospitals valued at Rs 24 billion for Apollo, as reported by Construction World.
Larsen & Toubro (L&T), a leading Indian multinational conglomerate, has bagged a significant contract from Apollo Hospitals to build multiple hospitals across the country. The total value of the contract is estimated to be around Rs 24 billion (approximately $330...
Apollo Cradle and Children’s Hospital, headquartered in Hyderabad, is poised for substantial growth with plans to launch 7-8 new facilities over the next five years. – TRIPURA STAR NEWS
Apollo Cradle and Children's Hospital, a prominent healthcare provider, has announced plans for significant expansion in the next five years. Headquartered in Hyderabad, the hospital aims to set up 7-8 new centers across the country, catering to the growing demand for...
Apollo Hospitals Introduces ‘Fleet of Hope’ on World Emergency Medicine Day to Promote Awareness About 1066 Emergency Services
On World Emergency Medicine Day, Apollo Hospitals launched the "Fleet of Hope" initiative to raise awareness about its 1066 emergency services. The campaign aims to educate the public about the importance of emergency medical services and the role they play in saving...
ZDS-Varenicline, a smoking cessation medication developed by Zydus Lifesciences, receives approval from Health Canada, as reported by geneonline.com.
Zydus Lifesciences, a leading pharmaceutical company, has received approval from Health Canada for its smoking cessation drug, ZDS-Varenicline. This approval marks a significant milestone for the company, as it expands its presence in the Canadian market....
Burn Pain Treatment Industry: Research, Therapies, and Key Players Including Johnson & Johnson, Mankind Pharma, Perrigo Company, Pfizer, Smith & Nephew, Sun Pharmaceutical, and Trio Li.
The burn pain market is a growing industry that is expected to expand due to the increasing incidence of burn injuries worldwide. According to DelveInsight, the market is driven by the rising demand for effective pain management therapies for burn patients. Burn pain...
CureVac and GSK have reached an agreement to settle their ongoing patent dispute with Pfizer and BioNTech.
CureVac, a German biotechnology company, and GlaxoSmithKline (GSK) have agreed to resolve a patent dispute litigation with Pfizer and BioNTech related to COVID-19 vaccine technology. The dispute centered on the use of messenger RNA (mRNA) technology, which is a key...
The Steroid Implant Market is Expected to Experience Significant Growth, with Key Players such as Novartis, Allergan, and Pfizer Driving the Trend.
The Global Steroid Implant Market Study, conducted by HTF Market Intelligence, provides a comprehensive analysis of the market from 2025 to 2033. The report spans over 143 pages and covers the product and industry scope, market prognosis, and status. The market is...
Pfizer’s CEO is set to attend a $25 million fundraising event hosted at one of Donald Trump’s golf courses, despite the President’s recent calls for the pharmaceutical company to lower its drug prices, according to sources.
Pfizer CEO Albert Bourla is expected to attend a fundraiser for President Trump's super PAC, MAGA Inc., at his golf club in Bedminster, New Jersey. The event aims to raise $25 million. However, the meeting comes at an interesting time, as President Trump has been...
Global Digoxin Industry Analysis: An In-Depth Report Featuring Key Players Such as Pfizer, Novartis, and Mylan
The Global Digoxin Market study, recently introduced by HTF MI, provides a comprehensive overview of the product and industry scope, as well as an in-depth analysis of the market outlook and status from 2025 to 2031. The market is segmented by key regions, including...
Pfizer and XtalPi Broaden Partnership to Accelerate AI-Powered Drug Development and Materials Science Research
XtalPi, a leading technology company, has announced an expansion of its research collaboration with Pfizer to develop a next-generation molecular modeling platform for drug discovery. The goal of this initiative is to improve the accuracy of advanced physics-based...
My life as a fit father of four was turned upside down after receiving the Pfizer Covid vaccine, sparking a devastating chain of events that has cost me £100,000 in a desperate search for a cure.
Dean Valentine, a 59-year-old grandfather from Essex, claims that his life was turned upside down after receiving the Pfizer Covid vaccine in December 2021. Prior to the vaccine, Valentine was a healthy and active individual who enjoyed golfing, holidays, and spending...
Fortis acquires Shrimann hospital in a massive Rs 462 crore deal
Fortis Healthcare has expanded its presence in Punjab by acquiring the 228-bed Shrimann Superspecialty Hospital for a consideration of Rs 462 crore. This marks the fifth hospital of Fortis in Punjab, with existing hospitals in Ludhiana, Mohali, and Amritsar. The...
Fortis Hospital ordered to compensate Rs 50 lakh for medical negligence
The District Consumer Disputes Redressal Commission in Chandigarh has held Fortis Hospital in Mohali and one of its doctors guilty of medical negligence. The commission has ordered the hospital to pay a compensation of Rs 50 lakh along with 9% interest per annum to...
Fortis and Agilus Enhance Genomic Testing Capabilities with Additional Genexus System, Accelerating Cancer Diagnosis.
Fortis and Agilus have partnered to enhance genomic testing capabilities with the installation of a second Genexus system. This move is expected to significantly improve the speed and accuracy of cancer diagnosis. The Genexus system is a next-generation sequencing...
Fortis Hospital, Manesar Achieves Breakthrough in Treating 38-Year-Old Stage 4 Head and Neck Cancer Patient with Innovative Targeted Oral Therapy
A 38-year-old man diagnosed with stage 4 head and neck cancer has successfully undergone treatment at Fortis Hospital, Manesar, using targeted oral therapy. The patient, who was initially diagnosed with a tumor in his throat, had been experiencing symptoms such as...
On World Kidney Cancer Day, physicians at Mohali’s Fortis Hospital launch an initiative to educate the public about the causes and symptoms of kidney cancer.
On June 19, World Kidney Cancer Day, doctors at Fortis Hospital in Mohali are raising awareness about the increasing incidence of kidney cancer in India. They are highlighting the symptoms of the disease, which include abdominal pain, swelling in the abdomen,...
Manipal and Fortis are engaging in discussions to secure Rs 5,000 crore for a potential acquisition of Sahyadri Hospitals.
The bidding process for Sahyadri Hospitals, a multispecialty hospital chain, is nearing its deadline of June 22. Interested bidders, including Manipal Health Enterprises and Fortis Healthcare, are in talks with foreign lenders to secure financing of up to Rs 5,000...
Fortis Healthcare launches state-of-the-art outpatient clinic for specialized care in Guwahati, as reported by Healthcare Asia Magazine
Fortis Healthcare, a leading integrated healthcare delivery service provider, has launched a super-speciality outpatient clinic in Guwahati, Assam. The clinic, which is the first of its kind in the region, aims to provide access to quality healthcare services to the...
Fortis Hospital Bannerghatta Road Successfully Treats 3-Year-Old Girl Suffering from Aggressive Blood Cancer Complicated by Life-Threatening Condition
A 3-year-old girl, Baby Ria, was successfully treated for Pre-B Acute Lymphoblastic Leukemia (ALL) at Fortis Hospital, Bannerghatta Road, Bengaluru. She was diagnosed with the aggressive form of blood cancer after presenting with high-grade fever, facial swelling, and...